Table 4.
Summary of meta-analysis and GRADE assessments of quality of data about different outcome measures of randomized compared trials comparing ECT and antipsychotic medication versus medication alone in the treatment of treatment refractory schizophrenia
| outcomes | number of studies (pooled sample) |
test for heterogeneity | analytic model | test for overall effect | estimate | 95% confidence interval of estimate | GRADE | ||
|---|---|---|---|---|---|---|---|---|---|
| I2 | p | Z | p | ||||||
| effectiveness | 18 (1394) | 38% | 0.05 | fixed | 7.51 | <0.001 | 1.31 (RR) | 1.22-1.41 | moderate |
| side effect (TESS) | 6 (534) | 81% | < 0.01 | - | - | - | - | - | very low |
| cognitive function | 4 (199) | 65% | 0.04 | random | 1.14 | 0.25 | -0.28 (SMD) | -0.77-0.20 | very low |
| overall function | 3 (157) | 48% | 0.14 | fixed | 7.26 | <0.01 | 10.25 (MD) | 7.48-13.01 | very low |
GRADE, Grades of Recommendation, Assessment, Development, and Evaluation
ECT, electroconvulsive therapy
TESS, Treatment Emergent Symptom Scale[37]
RR, risk ratio
SMD, standardized mean difference
MD, mean difference